Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal
The move marks a sign the company is bulking up on rare disease medicines as its older multiple sclerosis drugs face tepid demand due to rising competition.
—————
Boost Internet Speed–
Free Business Hosting–
Free Email Account–
Dropcatch–
Free Secure Email–
Secure Email–
Cheap VOIP Calls–
Free Hosting–
Boost Inflight Wifi–
Premium Domains–
Free Domains
